Financial statements Profarm Ps
Balance sheet data of PROFARM PS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 72 562 550,90 | 95 916 451,29 | 132 811 633,33 | 162 970 347,08 | 208 860 200,65 | 198 113 294,82 |
| A. Fixed assets | 7 983 608,64 | 8 357 353,14 | 8 109 512,49 | 8 136 527,72 | 9 448 031,26 | 10 665 181,40 |
| B. Current assets | 64 578 942,26 | 87 559 098,15 | 124 702 120,84 | 154 833 819,36 | 199 412 169,39 | 187 448 113,42 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 72 562 550,90 | 95 916 451,29 | 132 811 633,33 | 162 970 347,08 | 208 860 200,65 | 198 113 294,82 |
| A. Equity | 20 011 697,31 | 21 770 533,77 | 23 398 193,75 | 27 400 568,82 | 27 633 051,37 | 33 710 881,34 |
| B. Liabilities and provisions for liabilities | 52 550 853,59 | 74 145 917,52 | 109 413 439,58 | 135 569 778,26 | 181 227 149,28 | 164 402 413,48 |
| I. Long-term liabilities | 860 250,60 | 1 084 578,89 | 836 101,37 | 1 325 181,21 | 1 873 822,90 | 2 296 459,66 |
| II. Short-term liabilities | 50 682 141,28 | 71 961 614,00 | 107 783 273,50 | 133 073 709,53 | 177 644 847,82 | 159 354 264,26 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.